Mark Kirtland
Mark Kirtland serves as managing director of Pyxis Advisors, where he consults with private equity firms, venture capitalists, and medical technology companies on corporate strategy, new product commercialization, R&D prioritization, and corporate development projects.
Most recently he served as the vice president of corporate development at Oxford Immunotec. He previously served as senior vice president of corporate development at OraSure Technologies, and held a number of commercial and strategic roles at Cytyc (acquired by Hologic) and LipoScience (acquired by LabCorp).
Mark began his career as an associate at McKinsey and Co. after receiving an MS in bioengineering from Columbia University and a BS in biology from Christian Brothers University.